The Study
Unknown Title
This study is like a summary of other people’s science reports — it tells you what they found about how the body fights a fungus called Pneumocystis, but it didn’t do any experiments itself. So it can say 'people with weak immune systems get sick more,' but it can’t say 'changing this cell will cure you.'
Analysis score
Maximum 5 for a narrative review.
Where the score came from
Your body uses special white blood cells called T-cells to fight a fungus called Pneumocystis. If you have too few of the main ones (CD4 cells), you get sick. Other T-cells use IL-17 to kill the fungus, but IFN-γ doesn't kill it—it just stops your lungs from getting too inflamed.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 51 / 100
Quality score
Based on clinical experience or non-systematic literature reviews. The lowest level of evidence as they are most susceptible to bias and personal perspective.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes—people with HIV or weakened immune systems often have low CD4 counts and get this pneumonia; understanding which cells help or hurt could lead to better treatments.
- 2CD4 counts below 200 cells/mm³ = much higher risk of pneumonia.
- 3Removing IL-17 = 36x more fungus in mouse lungs.
- 4Removing IFN-γ = same fungus, but worse lung swelling.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Related Content
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.